21.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVDL Giù?
Forum
Previsione
Avadel Pharmaceuticals Plc Borsa (AVDL) Ultime notizie
Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plcAVDL - PR Newswire
Goldman Sachs (EPT)38.5bAVADEL PHARMACEUTICALS PLC - Research Tree
Geode Capital discloses 2.24% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Bank of America discloses 1.88% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 1.88% stake in Avadel Pharmaceuticals By Investing.com - Investing.com UK
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Canada
J.P. Morgan Securities discloses position in Avadel Pharmaceuticals - Investing.com
Citadel Group discloses 1.24% stake in Avadel Pharmaceuticals - Investing.com
Geode Capital discloses 2.25% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Australia
Bank of America discloses 2% stake in Avadel Pharmaceuticals - Investing.com
Citadel Group discloses 1.22% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley reports trading activity in Avadel Pharmaceuticals shares - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Janus Henderson discloses 3.73% stake in Avadel Pharmaceuticals - Investing.com
Janus Henderson discloses 3.73% stake in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Morgan Stanley discloses dealings in Avadel Pharmaceuticals securities By Investing.com - Investing.com Australia
Morgan Stanley discloses dealings in Avadel Pharmaceuticals securities - Investing.com
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com
Alkermes, Avadel Pharmaceuticals merger gets HSR clearance in US - MLex
Avadel Pharmaceuticals Acquisition by Alkermes Advances - TradingView
Citadel Group discloses 1.2% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Trium Capital discloses 1.29% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Citadel Group discloses 1.2% stake in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Bank of America discloses 1.12% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 1.12% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley reports trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com UK
FIL Limited discloses 2.9% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Janus Henderson discloses 3.84% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
REGFIL Limited Avadel Pharma plcForm 8.3AVADEL PHARMACEUTICALS PLC - TradingView
Janus Henderson discloses 3.84% stake in Avadel Pharmaceuticals - Investing.com
Discipline and Rules-Based Execution in AVDL Response - news.stocktradersdaily.com
Avadel Pharmaceuticals PLC (AVDL) - MSN
Is Avadel Pharmaceuticals Still Attractive After a 113.4% One Year Surge in 2025? - Sahm
How Recent Deal Developments Are Reshaping The Avadel Pharmaceuticals Investment Story - Yahoo Finance
Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge - MSN
Has Avadel’s 115% Rally in 2024 Already Priced In Its Narcolepsy Breakthrough? - Yahoo Finance
Avadel Pharmaceuticals plc and Alkermes plc Announce Proposed Transaction for Acquisition - Quiver Quantitative
Announcement relating to despatch of Rule 15 proposal - The Manila Times
Avadel (NASDAQ: AVDL) sends Rule 15 proposal to equity holders in Alkermes deal - Stock Titan
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):